ESMO 2014

Oncology Meeting Resources

26 Sep - 30 Sep 2014, Madrid, Spain

ESMO 2014 Congress

The theme for ESMO 2014 was ‘Precision Medicine in Cancer Care.’ Whether you are a medical or surgical oncologist or a radiation oncologist, immunologist or pathologist, practising precision medicine means we are all working towards a common goal – improved patient outcomes. For your convenience and due to the large quantity of information coming from the ESMO 2014 congress, we have split the presentations up by main congress topic to allow you to find the information you need more easily.

Here, you will find the abstracts, posters, PDF presentation and webcasts from ESMO 2014 to the extent the presenters have consented to release their contribution or a slightly modified version thereof. Please, note that the publication of these presentations is a courtesy of the originating authors and is for personal educational purposes only.

Drug Index of ESMO 2014 Abstracts

Special Sessions and Tracks

Useful links





Format available

http://oncologypro.esmo.org/Meeting-Resourc...iscussant-abstracts-1183PD-1184PD-and-1557PD

Date: 27 Sep 2014
Presenter: Enriqueta Felip
Resources: Presentation, Webcast
Topic: Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...ults-from-the-phase-3-studies-ROMANA-1-and-2

Aim Cancer anorexia-cachexia syndrome is a common debilitating condition, characterized by decreased body weight, mainly lean body mass (LBM) and negatively impacts quality of life and prognosis.

Date: 27 Sep 2014
Presenter: Jennifer Temel
Resources: Abstract, Presentation, Webcast
Topics: Supportive Care, Lung and other Thoracic Tumours

http://oncologypro.esmo.org/Meeting-Resourc...al-applications-for-microRNAs-in-lung-cancer

BodyNo abstract received at time of going to press

Date: 27 Sep 2014
Presenter: Carlo Croce
Resources: Abstract, Presentation, Webcast
Topics: Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-insights-for-sequencing-data-in-lung-cancer

Body Abstract:Cases of non-small-cell lung cancer (NSCC) carrying EGFR mutations have been shown to be hyperresponive to EGFR tyrosine kinase inhibtors. Chromosomal translocations and corresponding...

Date: 28 Sep 2014
Presenter: Kazuto Nishio
Resources: Abstract, Presentation, Webcast
Topics: Lung and other Thoracic Tumours, Personalised Medicine, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...microRNA-signature-for-lung-cancer-detection

AimLung cancer (LC) screening using low-dose CT demonstrated a 20% reduction in lung cancer mortality in heavy smokers. However, this strategy has several limitations including high false-positive...

Date: 28 Sep 2014
Presenter: Ernest Nadal
Resources: Abstract
Topics: Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...cells-CTC-in-lung-cancer-Preliminary-results

AimThe value of CTC is unclear in patients (p) with lung cancer, in particular in those with locally advanced disease.MethodsBasally peripheral blood samples are been collected for prospective CTC...

Date: 28 Sep 2014
Presenter: Maria Eugenia Olmedo
Resources: Abstract
Topics: Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...rectal-cancer-and-non-small-cell-lung-cancer

AimKRAS mutation testing is mandatory prior to prescribing anti-EGFR antibodies to colorectal cancer (CRC) patients. KRAS is also the most frequently mutated oncogene in non-small cell lung cancer (NSCLC).

Date: 28 Sep 2014
Presenter: Sung Lee
Resources: Abstract
Topics: Biomarkers, Colon Cancer, Rectal Cancer, Lung and other Thoracic Tumours, Pathology/Molecular Biology

http://oncologypro.esmo.org/Meeting-Resourc...atients-with-ovarian-lung-and-breast-cancers

AimHeregulin (HRG)-driven ErbB3 signaling mediates resistance to standard-of-care (SOC) cancer therapy in a variety of preclinical models. MM-121, a HRG-blocking anti-ErbB3 antibody, underwent clinical...

Date: 28 Sep 2014
Presenter: Gavin MacBeath
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Ovarian Cancer, Breast Cancer, Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-to-detect-lung-cancer-in-human-blood-plasma

AimUntil today no effective method permits the early detection of lung cancer. Evidence has shown that disturbances in biochemical pathways which occur during the development of cancer provoke, changes in the metabolic phenotype.

Date: 28 Sep 2014
Presenter: Michiel Thomeer
Resources: Abstract
Topics: Diagnostics, Lung and other Thoracic Tumours, Translational Research

http://oncologypro.esmo.org/Meeting-Resourc...-vintafolide-treatment-by-using-etarfolatide

AimCompanion diagnostics for cancer are frequently inaccurate as they are tissue based and do not account for heterogeneity of metastatic lesions and/or were obtained at remote time points.

Date: 28 Sep 2014
Presenter: Edward Garon
Resources: Abstract
Topics: Anti-Cancer Agents & Biologic Therapy, Diagnostics, Lung and other Thoracic Tumours